Informed Consent Management
Streamlining Informed Consent Data Identification and Validation for Clinical Research
Informed Consent Documents (ICDs) are central to clinical research, as they define how participant data and specimens can be used, reused, or restricted. As clinical programs grow in scale and complexity, identifying and validating consent data across multiple ICDs becomes increasingly difficult. This case study highlights how Princeton Blue helped a global life sciences company to treat informed consent data as a structured, decision-ready asset rather than a manual review exercise. By simplifying how consent information was identified and validated, teams reduced delays, improved consistency, and gained a scalable foundation for supporting research at speed.
Challenges
Our client is a large, global biopharmaceutical company conducting clinical research across multiple therapeutic areas and geographies. Before participant data or specimens could be referenced or used, business teams were required to validate consent information. This made ICD interpretation a foundational step in the research lifecycle and a critical dependency for downstream research and lab teams.
To validate consent for a study request, business users manually reviewed data from the Transfer File Master (PTMF) portal and cross-checked multiple ICDs to determine:
- Which sample types were permitted
- Whether future use was allowed and under what restrictions
- Applicable opt-out conditions
- Retention periods and limitations
This approach was slow and highly dependent on individual interpretation. Users had to sift through lengthy documents, reconcile differences across versions, and apply judgment to determine whether consent criteria were met.
As study volumes increased, this created several challenges:
High manual effort
Risk of inconsistency
Limited scalability
Downstream delays
Poor visibility
The organization needed a structured, repeatable way to identify and validate consent data – one that reduced manual effort while improving accuracy and confidence.
Solution
Princeton Blue implemented a solution using the Process Automation and Agentic AI capabilities of the Appian Platform to accurately identify and validate informed consent data from Informed Consent documents and make it structured, trusted, and easy to work with.
Centralized Clinical Document Repository
AI Agents for Data Extraction
Structured & Contextualized Clinical Data Views
Verification-Ready Document Preparation
Version Control & Traceability
Intuitive Dashboards for Clinical Operations
Impact
The solution delivered measurable improvements across efficiency, accuracy, and scalability:
- 40,000+ ICD files were processed using AI-powered extraction
- ~80% extraction accuracy reduced reliance on manual interpretation
- Consent validation turnaround time was reduced from days to hours
- Manual review effort was significantly reduced across business teams
- Study-level visibility improved collaboration with research and lab teams
- The process scaled effectively to support growing study volumes and additional document types